Hypothalamo-preoptic histaminergic projections in sleep-wake control in the cat.
Cats were chronically implanted with electrodes for polygraphic recordings and cannulae for intracerebral microinjections in order to study the functional role of histaminergic innervation of the preoptic-anterior hypothalamus in sleep-wake control. alpha-Fluoromethylhistidine (alpha FMH, 50 micrograms in 1 microliter), a specific inhibitor of the histamine-synthesizing enzyme, when injected bilaterally into the preoptic area, where numerous histaminergic fibres and terminal-like structures are present, caused a significant increase in deep slow wave sleep (S2) and paradoxical sleep (PS) and a decrease in wakefulness. In contrast, microinjections of histamine (5 or 30 micrograms in 1 microliter) in the same area dose-relatedly increased wakefulness and decreased both slow wave sleep and paradoxical sleep. The effects of histamine were reduced by pretreatment with mepyramine (1 mg/kg i.p.), a well known histamine H1 receptor antagonist, and were mimicked by a local injection of impromidine (1 microgram in 1 microliter), a potent histamine H2 receptor agonist. Microinjections of mepyramine alone (120 micrograms in 1 microliter) caused an increase in slow wave sleep. These results suggest that preoptic histaminergic innervation is involved in sleep-wake control and that the action might be mediated via both H1 and H2 receptors.
Département de Médecine Expérimentale, INSERM U52, CNRS UA 1195, Université Claude Bernard, Lyon, France.
J S
JS
Lin
K
K
Sakai
M
M
Jouvet
D000818:Animals; D001921:Brain / Q000502:physiology*; D002415:Cats / Q000502:physiology*; D004305:Dose-Response Relationship, Drug; D004569:Electroencephalography / Q000187:drug effects; D005260:Female; D006632:Histamine / Q000008:administration & dosage / Q000494:pharmacology / Q000502:physiology*; D006640:Histidine Decarboxylase / Q000037:antagonists & inhibitors; D007032:Hypothalamus, Anterior / Q000166:cytology / Q000187:drug effects / Q000502:physiology*; D017446:Impromidine / Q000008:administration & dosage / Q000494:pharmacology; D008297:Male; D008762:Methylhistidines / Q000008:administration & dosage / Q000494:pharmacology; D008845:Microinjections; D011301:Preoptic Area / Q000166:cytology / Q000187:drug effects / Q000502:physiology*; D011738:Pyrilamine / Q000008:administration & dosage / Q000494:pharmacology; D012890:Sleep / Q000187:drug effects / Q000502:physiology*; D012895:Sleep, REM / Q000187:drug effects / Q000502:physiology; D013997:Time Factors; D014851:Wakefulness / Q000187:drug effects / Q000502:physiology*
D008762:Methylhistidines; C028309:alpha-fluoromethylhistidine; D006632:Histamine; D017446:Impromidine; D006640:Histidine Decarboxylase; D011738:Pyrilamine